Hans-heinrich Oberg

Kiel, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2025

Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assays.

Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assays.

Journal: Frontiers in immunology

Published: November 04, 2025

Correction: Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer.

Correction: Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer.

Journal: Frontiers in immunology

Published: July 23, 2025

Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer.

Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer.

Journal: Frontiers in immunology

Published: May 14, 2025

Function and Spatial Organization of Tumor-Invasive Human γδ T Cells-What Do We Know?

Function and Spatial Organization of Tumor-Invasive Human γδ T Cells-What Do We Know?

Journal: European journal of immunology

Published: July 02, 2024

Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.

Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.

Journal: Frontiers in immunology

Published: August 30, 2023

Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn's disease.

Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn's disease.

Journal: Nature medicine

Published: March 08, 2023

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.

Journal: Blood

Published: June 01, 2022

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.

Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.

Journal: Biological chemistry

Published: April 12, 2021

Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.

Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 01, 2020

Tumor resistance mechanisms and their consequences on γδ T cell activation.

Tumor resistance mechanisms and their consequences on γδ T cell activation.

Journal: Immunological reviews

Published: August 03, 2020

Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.

Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.

Journal: Cells

Published: April 03, 2020

Showing 1-12 of 62

Last Updated: 09/26/2026